Are Deep Health AI India Ltd latest results good or bad?

The latest financial results for Deep Health AI India Ltd for the quarter ended March 2026 reveal significant operational challenges. The company reported a net loss of ₹4.51 crores, marking a dramatic shift from profitability in the previous year and indicating a substantial decline in financial health. Revenue for the quarter was ₹0.25 crores, which reflects a year-on-year decrease of 44.44% from ₹0.45 crores in the same quarter last year. This decline in revenue is compounded by a notable operational breakdown, as the company experienced a 50% drop in sales compared to the previous quarter. The operating profit before depreciation, interest, and tax was a mere ₹0.05 crores, translating to an operating margin of 20%, which, while stable, is based on a very low revenue base. The company's reliance on other income, which exceeded operating profit, further highlights the underlying weaknesses in its core business operations. The financial data indicates that the company is facing severe volatility and instability, with a profit before tax of negative ₹5.54 crores on minimal revenue, suggesting the presence of significant exceptional charges or write-offs that have not been detailed in the available information. This situation raises serious concerns regarding asset quality and the overall viability of the business model. Additionally, the company's average return on equity over the past five years stands at 7.89%, which is below acceptable standards, and the average return on capital employed is just 1.96%. These figures suggest that the company is struggling to generate adequate returns relative to its capital employed. In terms of shareholding, there has been a noticeable reduction in institutional interest, with foreign institutional investors decreasing their stake significantly. The absence of promoter holding and minimal institutional credibility further complicates the company's outlook. Overall, Deep Health AI India Ltd's recent performance reflects a company in distress, grappling with severe operational challenges and a lack of sustainable revenue generation. The company has seen an adjustment in its evaluation, which underscores the need for careful monitoring of its financial health and operational viability moving forward.